NGL Fine Chem Share Price

NGL Fine-Chem Limited is an India-based company, which is a manufacturer of pharmaceuticals and intermediates for use in veterinary and human health. The Company caters to various global companies to custom manufacture pharmaceuticals. Its products include APIs Animal Health, APIs Human Health, Intermediates and Specialty Chemicals and Finished Dosage Form. The APIs Animal Health products include Homidium Chloride, Nitroxynil, Clorsulon, Parvaquone, Buparvaquone, Isometamidium Chloride Hydrochloride, Toldimfos Sodium, Butaphosphan, Imidocarb Dipropionate, Triclabendazole, Rafoxanide, Diminazene Aceturate, S-Methoprene, Carprofen and others. The APIs Human Health products include Nitazoxanide and Atovaquone. The Intermediates and Specialty Chemicals product includes 1,4,7-Trimethyl-1,4,7-Triazacylononane and N-Ethyl Glucamine. The Finished Dosage Form products include Diminazene Aceturate Granules and Homidium Chloride Tablets. It has manufacturing plants located around Mumbai.As of 14 Jun 2026, NGL Fine Chem share price is ₹3,048.80. The stock opened at ₹2,765.40, compared to its previous close of ₹2,716.50. During today's trading session, NGL Fine Chem share price moved in the range of ₹2,765.40 to ₹3,144.00, with an average price of ₹2,954.70 for the day. Looking at its last 52-week, the stock has touched a low of ₹2,765.40 and a high of ₹3,144.00. On the performance front, NGL Fine Chem share price has increased by 129.80% over the last six months and is up 187.62% on a year-on-year basis.

The market capitalization of NGL Fine Chem is ₹1,893 Crs, with a P/E ratio of 39.3 and a dividend yield of 0.06%.